Knowledge Distillery

Filter the news according their assigned tags.

In this paper, recently published in Neurocritical Care, the authors conducted a retrospective cohort study of patients with haemorrhagic stroke (both…

more...

Acute cerebrovascular disease, particularly ischaemic stroke, has emerged as a serious complication of COVID-19.

 

more...

In this study, the authors examined the association of in-hospital anticoagulation (AC) in COVID-19 patients with in-hospital outcomes and described…

more...

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

more...

In this multicentre retrospective observational cohort study recently published in Lancet Rheumatology, the authors investigate the association…

more...
| Case series/case reports  

In this paper, the authors retrospectively reviewed all COVID-19–positive patients admitted to the neuroscience intensive care unit for monitoring of…

more...
| Case series/case reports  

The aim of this retrospective, observational cohort study, published in Lancet Rheumatology, was to assess the role of tocilizumab in reducing the…

more...
| Interventional study with open label/non-randomised methodology  

The objective of this prospective, open-label, randomised clinical trial, was to evaluate the effect of treatment with colchicine on cardiac and…

more...
| Interventional study with open label/non-randomised methodology  

In this controlled, open-label trial recently published in the New England Journal of Medicine, the authors randomly assigned patients who were…

more...
| Case series/case reports  

In this article the authors identify four receptor-binding domain targeting antibodies from three early-outbreak convalescent donors with potent…

more...
| Interventional study with open label/non-randomised methodology  

In this article the authors assessed whether azithromycin is effective in reducing hospital admission in patients with mild-to-moderate COVID-19.

more...
| Interventional study with open label/non-randomised methodology  

This phase 3 trial randomly assigned a cohort of patients with mild or moderate COVID-19 who were at high risk for progression to severe disease to…

more...